With multiple concussions between the two of them, Dan Han and Lisa Koehl's latest research interest isn't surprising.
"I played competitive soccer through high school and continue to play recreationally," says Koehl, a doctoral candidate in the University of Kentucky's Department of Psychology, "so I have firsthand experience with the dynamics that come into play when a teen suffers a concussion."
As a former high school assistant principal in the Chicago public school system, Han was responsible for overseeing student-athletes' return to school after a concussion.
A multicenter study including University of Kentucky researchers found that a new nerve repair technique yields better results and fewer side effects than other existing techniques.
Traumatic nerve injuries are common, and when nerves are severed, they do not heal on their own and must be repaired surgically.
Prior to medical school, members of the University of Kentucky College of Medicine Class of 2018 were chemists, Americorp volunteers, engineers, waiters, musicians, class leaders and archeologists. But the moment they were coated at the Singletary Center of the Arts on Aug. 1, the 136 students were all dedicated to becoming doctors.
Members of a diverse and highly accomplished incoming class of medical students were presented with their white coat, a universal symbol of compassion and humanism in medicine, during the White Coat Ceremony. Dr. Frederick C.
Prabhakara R Nagareddy, a scientist with the Saha Cardiovascular Research Institute at the University of Kentucky, has received a prestigious K99/R00 award from the National Institutes of Health.
Also known as the Pathway to Independence (PI) Award, this grant provides two years of mentored postdoctoral support followed by three years of independent support.
University of Kentucky Endowed Chair of Neuroscience Dr. Diane Snow was recently elected by her colleagues to serve as president-elect of the National Neurotrauma Society (NNS). With this appointment, Snow will hold the position of president in 2015-2016.
Since joining the NNS in 2003, Snow has championed women's contributions to neurotrauma research and mentorship opportunities for young members of the profession, including students, postdoctoral fellows and young professors.
Tetsuhiro Yasuma, postdoctoral Fellow in the Department of Ophthalmology and Visual Sciences at the University of Kentucky College of Medicine, has been selected to receive the 2014 Fight for Sight Postdoctoral Award from Fight for Sight, a non-profit organization that promotes eye research by providing pilot funding to promising new researchers.
Yasuma received training in biomedical research as an undergraduate student in Japan and general ophthalmology and surgery in graduate school. Yasuma joined the Ambati lab at UK in 2012.
Most people hear the word "artifact" and think of amazing items found by archeologistsat a dig -- objects that shed light on bygone cultures.
For Dr. Vincent Sorrell, and his colleagues on the Gill Heart Institute's Advanced Cardiovascular Imaging team, the thought of artifacts means a challenge but one they have worked to overcome.
University of Kentucky medical residents, fellows and faculty members packed into a classroom next to the medical center library on July 16 to practice fundamental newborn resuscitation maneuvers on baby mannequins.
The Helping Babies Breathe training didn't teach these pediatric professionals anything new — they were all familiar with the process of drying, suctioning and ventilating a newborn with breathing problems.
A new study by University of Kentucky researchers shows how a genetic defect in a specific hormonal pathway may make people more susceptible to developing melanoma, the deadliest type of skin cancer.
Fair-skinned people who tend to burn (rather than tan) from sun exposure have a much higher risk for melanoma than darker-skinned people. On the surface, it appears that the amount of melanin, the natural substance in the skin that determines pigment and acts as the skin's "natural sunscreen," would be the only determinant of melanoma risk.
The Bright Focus Foundation has announced that three different researchers from the Sanders-Brown Center on Aging at the University of Kentucky have received Bright Focus grants for 2014.
Professor Steve Estus and associate professors Harry LeVine and Paul Murphy were each recognized for their work on Alzheimer's disease.
"Only 25 Bright Focus grants are awarded worldwide each year, so it's an achievement to get one. But three Bright Focus grants in a single year is truly exceptional," said Dr. Michael Karpf, UK HealthCare's executive vice president of health affairs.
A year ago, a crowd of hundreds gathered in Pavilion A of the University of Kentucky Chandler Hospital to celebrate a long-awaited special announcement – the unveiling of the UK Markey Cancer Center as the state's first and only National Cancer Institute-designated cancer center.
The designation was the culmination of years of tireless work by the faculty and staff of Markey and its supporting service lines and colleges – all guided by Director Dr.
In the mid-1990's, Dr. Maya Guglin was a cardiologist in Volgograd, Russia.
"I was working in a 1,000-bed university hospital treating critically ill patients in the critical care unit (CCU)," Guglin says. "I had some terrific teachers and wonderful colleagues. But I felt as if something were missing…..that there were opportunities to expand my knowledge and experience that I couldn't get in my home country."
Researchers from the Sanders-Brown Center on Aging at the University of Kentucky have been able to confirm anecdotal information on patients with both Alzheimer's disease (AD) and cerebrovascular disease (CVD) using mouse models in two different studies.
The findings of these two studies, which were recently published in Acta Neuropathologica and Alzheimer's Research & Therapy, have potentially significant implications for patients with both disorders.
Both papers studied CVD in Alzheimer's disease mouse models using different lifestyle factors.
Scientists at the University of Kentucky, led by nano-biotechnologist Peixuan Guo, have made some critical discoveries over the past year into the operation of biomotors, the molecular machines used by viruses and bacteria in the packaging of DNA.
Biomotors function similarly to mechanical motors but on a nano-scale. Last year, Guo's team reported the discovery of a new, third class of biomotor, unique in that it uses a "revolution without rotation" mechanism. Rotation is the turning of an object around its own axle, as the Earth does every 24 hours.
Not all learning experiences are created equally – and at the Learning Center at Linlee, an innovative partnership with the University of Kentucky College of Medicine allows young students to get rich, hands-on experience in the sciences and better their chances of succeeding in college and beyond.
As part of the Fayette County Public School System, The Learning Center (TLC) is an alternative school for at-risk students who are facing personal challenges that might impede their ability to learn. These include socioeconomic factors, and, perhaps surprisingly, intellectual giftedness.
UK HealthCare and Norton Healthcare are building upon their history of collaboration to expand research and educational collaborations between the two institutions, with the goal of improving health and health care for all Kentuckians.
Beginning July 1, educational and research initiatives between UK and Norton will be lead by Dr. Stephen Wyatt, who most recently served two successful terms as the founding dean of the University of Kentucky College of Public Health.
At first glance, it may not seem that the chair of cardiothoracic surgery in the University of Kentucky College of Medicine and a horticultureextension professor and specialist in the UK College of Agriculture, Food and Environment would share the same research interests. But Sibu Saha and his son 
The University of Kentucky's Sanders-Brown Center on Aging is participating in a landmark multi-center clinical trial of an experimental drug that has the potential to prevent Alzheimer's disease (AD).
The A4 Study will recruit 1,000 participants ages 65-85 to test an amyloid antibody that may prevent memory loss caused by Alzheimer's disease. Amyloid is a protein normally produced in the brain that can build up in older people, forming plaque deposits in the brain.
New researchers in any field face challenges--limited research experience, competing demands for time, diminished levels of and increased competition for funding.
